169 related articles for article (PubMed ID: 16978199)
61. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
62. A subset of prostate basal cells lacks the expression of corresponding phenotypic markers.
Man YG; Zhao C; Chen X
Pathol Res Pract; 2006; 202(9):651-62. PubMed ID: 16842934
[TBL] [Abstract][Full Text] [Related]
63. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
64. Keratin expression in breast cancers.
Shao MM; Chan SK; Yu AM; Lam CC; Tsang JY; Lui PC; Law BK; Tan PH; Tse GM
Virchows Arch; 2012 Sep; 461(3):313-22. PubMed ID: 22851038
[TBL] [Abstract][Full Text] [Related]
65. Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.
Khilko N; Wang J; Wei B; Hicks DG; Tang P
Breast Cancer (Auckl); 2010 Oct; 4():49-55. PubMed ID: 21151863
[TBL] [Abstract][Full Text] [Related]
66. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
67. [Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma].
Ivković-Kapicl T; Panjković M; Nikolić I; Djilas-Ivanović D; Knezević-Usaj S
Vojnosanit Pregl; 2012 Dec; 69(12):1031-8. PubMed ID: 23424955
[TBL] [Abstract][Full Text] [Related]
68. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
69. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR
Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540
[TBL] [Abstract][Full Text] [Related]
70. Basal markers and prognosis in luminal breast cancer.
Engstrøm MJ; Valla M; Bofin AM
Breast Cancer Res Treat; 2017 Jun; 163(2):207-217. PubMed ID: 28258354
[TBL] [Abstract][Full Text] [Related]
71. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR
Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275
[TBL] [Abstract][Full Text] [Related]
72. Do columnar cell lesions exist in the male breast?
Verschuur-Maes AH; Kornegoor R; de Bruin PC; Oudejans JJ; van Diest PJ
Histopathology; 2014 May; 64(6):818-25. PubMed ID: 24267518
[TBL] [Abstract][Full Text] [Related]
73. Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma.
Perry KD; Reynolds C; Rosen DG; Edgerton ME; T Albarracin C; Gilcrease MZ; Sahin AA; Abraham SC; Wu Y
Histopathology; 2011 Oct; 59(4):619-30. PubMed ID: 22014043
[TBL] [Abstract][Full Text] [Related]
74. Coexpression of cytokeratins typical for columnar and squamous differentiation in sinonasal inverted papillomas.
Schwerer MJ; Kraft K; Baczako K; Maier H
Am J Clin Pathol; 2001 May; 115(5):747-54. PubMed ID: 11345840
[TBL] [Abstract][Full Text] [Related]
75. The 3-layered ductal epithelium in gynecomastia.
Kornegoor R; Verschuur-Maes AH; Buerger H; van Diest PJ
Am J Surg Pathol; 2012 May; 36(5):762-8. PubMed ID: 22314184
[TBL] [Abstract][Full Text] [Related]
76. The intermediate filaments and prognostically oriented morphological classification in ductal breast carcinoma.
Rejthar A; Nenutil R
Neoplasma; 1997; 44(6):370-3. PubMed ID: 9605010
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathological and immunohistochemical study of 39 cases of Adenomatoid Odontogenic Tumour: a multicentric study.
Leon JE; Mata GM; Fregnani ER; Carlos-Bregni R; de Almeida OP; Mosqueda-Taylor A; Vargas PA
Oral Oncol; 2005 Sep; 41(8):835-42. PubMed ID: 15979930
[TBL] [Abstract][Full Text] [Related]
78. The cytokeratin profile of medullary carcinoma of the breast.
Tot T
Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242
[TBL] [Abstract][Full Text] [Related]
79. Metaplastic carcinomas of the breast (light microscopic and immunohistochemical features).
Agrawal K; Kaur M; Bajaj P; Agrawal C; Pathania OP
Indian J Cancer; 2001; 38(2-4):80-4. PubMed ID: 12593444
[TBL] [Abstract][Full Text] [Related]
80. A study of cytokeratin profiles in localized cutaneous amyloids.
Chang YT; Liu HN; Wang WJ; Lee DD; Tsai SF
Arch Dermatol Res; 2004 Jul; 296(2):83-8. PubMed ID: 15141317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
